Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in VSports app下载. gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure V体育官网. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. .

. 2012;7(6):e39813.
doi: 10.1371/journal.pone.0039813. Epub 2012 Jun 29.

VSports - Methylation markers of early-stage non-small cell lung cancer

Affiliations

"V体育安卓版" Methylation markers of early-stage non-small cell lung cancer

Kaie Lokk et al. PLoS One. 2012.

Erratum in

"V体育官网入口" Abstract

Background: Despite of intense research in early cancer detection, there is a lack of biomarkers for the reliable detection of malignant tumors, including non-small cell lung cancer (NSCLC). DNA methylation changes are common and relatively stable in various types of cancers, and may be used as diagnostic or prognostic biomarkers. VSports手机版.

Methods: We performed DNA methylation profiling of samples from 48 patients with stage I NSCLC and 18 matching cancer-free lung samples using microarrays that cover the promoter regions of more than 14,500 genes. We correlated DNA methylation changes with gene expression levels and performed survival analysis. V体育安卓版.

Results: We observed hypermethylation of 496 CpGs in 379 genes and hypomethylation of 373 CpGs in 335 genes in NSCLC. Compared to adenocarcinoma samples, squamous cell carcinoma samples had 263 CpGs in 223 hypermethylated genes and 513 CpGs in 436 hypomethylated genes. 378 of 869 (43. 5%) CpG sites discriminating the NSCLC and control samples showed an inverse correlation between CpG site methylation and gene expression levels. As a result of a survival analysis, we found 10 CpGs in 10 genes, in which the methylation level differs in different survival groups. V体育ios版.

Conclusions: We have identified a set of genes with altered methylation in NSCLC and found that a minority of them showed an inverse correlation with gene expression levels VSports最新版本. We also found a set of genes that associated with the survival of the patients. These newly-identified marker candidates for the molecular screening of NSCLC will need further analysis in order to determine their clinical utility. .

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Differential DNA methylation between NSCLC and normal lung samples.
DNA methylation levels are shown for the top 100 CpG sites with the highest delta Beta values (FDR corrected) of DNA methylation between cancer tissue and normal lung tissue. Methylation Beta-values are represented as row Z-scores. A heatmap was generated using unsupervised 2D hierarchical cluster analysis. Red indicates high methylation and blue indicates low methylation relative to the row mean.
Figure 2
Figure 2. CpGs’ distance from TSS.
We measured CpGs’ distance from the transcription start site (TSS). a) Distance from TSS of all the CpGs on the methylation array. b) Distance from TSS of hypermethylated CpGs (dotted line) and distance from TSS of hypomethylated CpGs (continuous line). On the x-axis, the distance from TSS is measured in bp-s, and on the y-axis N represents the number of CpGs.
Figure 3
Figure 3. The concordance between microarray and qRT-PCR measurements.
On the y-axis is shown average log2fold-change determined by Illumina array and qRT-PCR (8 sample pairs). Error bars indicate standard error of the mean (SEM).
Figure 4
Figure 4. Survival curves of 10 differentially methylated CpG sites.
We performed a survival test on each of the CpG sites. The methylation values are divided into 3 groups: low (0–0.25), medium (0.25–0.75) and high (0.75–1). As a result we found 10 CpG sites whose methylation level differs in different survival groups. The x-axis shows survival in years and the y-axis shows overall survival.

References

    1. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006;6:107–116. - PubMed
    1. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet. 2006;7:21–33. - PubMed
    1. Uribe-Lewis S, Woodfine K, Stojic L, Murrell A. Molecular mechanisms of genomic imprinting and clinical implications for cancer. Expert Rev Mol Med. 2011;13:e2. - PubMed
    1. Foley DL, Craig JM, Morley R, Olsson CA, Olsson CJ, et al. Prospects for epigenetic epidemiology. Am J Epidemiol. 2009;169:389–400. - PMC - PubMed
    1. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J. 2001;18:1059–1068. - PubMed

V体育官网 - Publication types

VSports手机版 - MeSH terms

"V体育安卓版" Substances